Levetiracetam Nexcape Pharmaceuticals Limited

Levetiracetam, the active ingredient in Levetiracetam Nexcape Pharmaceuticals Limited, is an anticonvulsant presented as an intravenous solution for parenteral use. It is employed to control partial‑onset seizures, generalized tonic‑clonic seizures, and other seizure types in adult and pediatric patients with epilepsy.

GNH USA supplies Levetiracetam Nexcape Pharmaceuticals Limited as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide with adherence to stringent quality standards, regulatory approvals and reliable cold‑chain logistics where required, through a robust supply chain.

Levetiracetam is an antiepileptic drug indicated for several seizure types.

- Partial‑onset seizures: Reduces the frequency of focal seizures when used as monotherapy or adjunct therapy. - Generalized tonic‑clonic seizures: Helps control convulsive episodes in patients with epilepsy. - Epilepsy (overall): Serves as a broad‑spectrum adjunct to manage various seizure manifestations.

Levetiracetam may cause a range of adverse reactions.

Common Side Effects: - Fatigue: Persistent tiredness reported by some patients. - Dizziness: Sensation of light‑headedness, especially after initiation. - Somnolence: Increased sleepiness or drowsiness. - Headache: Mild to moderate cranial pain. - Irritability: Mood changes including agitation. - Nausea: Gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe allergic reactions: Rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: Rare skin disorder with blistering. - Blood dyscrasias: Anemia, leukopenia, or thrombocytopenia. - Mood alterations: Depression or suicidal thoughts. - Hepatic dysfunction: Elevated liver enzymes. - Respiratory depression: When combined with other CNS depressants.

Before using levetiracetam, consider the following safety measures.

- Renal impairment: Monitor renal function and adjust therapy as needed. - Hepatic impairment: Use with caution; assess liver status. - Pregnancy: Risk category unknown; weigh benefits against potential risks. - Concomitant CNS depressants: Observe for enhanced sedation. - Behavioral changes: Watch for mood swings, aggression, or depression. - Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Levetiracetam can interact with other medicines; awareness helps maintain efficacy and safety.

Major Interactions (Avoid): - Strong enzyme inducers (e.g., carbamazepine, phenytoin, phenobarbital): May lower levetiracetam plasma levels. - Alcohol: Can increase central nervous system depression. - Other antiepileptics: May require dose adjustments to maintain seizure control.

Moderate Interactions (Monitor Closely): - CNS depressants (benzodiazepines, opioids): Potential additive sedation. - Renal excretion competitors (e.g., probenecid): May raise levetiracetam concentrations.